Takuma Hiramatsu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Takuma Hiramatsu has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Chihiro Takeuchi
Department of Gastroenterology, Graduate School of Medicine The University of Tokyo Tokyo Japan
1 shared publication - Dai Kubota
Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
1 shared publication - Daisuke Ohki
Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
1 shared publication - Hideki Nakagawa
Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
1 shared publication - Hikaru Kuribara
Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
1 shared publication - Hiroya Mizutani
Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
1 shared publication
Latest Publications
- Open Access
- 30 November 2025
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 58 (6) , 787-796
Recent advancement in endoscopic diagnosis for risk stratification of gastric cancer
Approximately 90% of cases of gastric cancer (GC) are caused by Helicobacter pylori infection, and screening esophagogastroduodenoscopy is effective for secondary prevention of GC. Endoscopic findings of the stomach due to H. pylori infection vary widely, and the risk of GC varies according to each finding. GC risk is evaluated by combining endoscopic and histopathological findings. In the operative link on gastritis assessment and operative link on gastric intestinal metaplasia assessment staging, GC risk is determined by histopathological evaluation. In the endoscopic grading of gastric intestinal metaplasia, Kyoto classification, and modified Kyoto classification, the risk is considered based on endoscopic findings. However, evaluating endoscopic findings is challenging because the evaluation varies depending on the skill of the endoscopist. Similarly, histopathological findings can be assessed differently by different pathologists. Histopathological evaluation by biopsy carries a risk of bleeding; thus, simpler and less-invasive risk stratification methods are desirable. Artificial intelligence for risk stratification, which has the potential for improved accuracy and consistency, has been developed for endoscopic and histopathological evaluations. Appropriate GC risk stratification would benefit the economy and patients, and further evaluation of surveillance intervals tailored to individual risks is warranted.
- 30 November 2025
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 58 (6) , 787-796
Open AccessRecent advancement in endoscopic diagnosis for risk stratification of gastric cancer
Approximately 90% of cases of gastric cancer (GC) are caused by Helicobacter pylori infection, and screening esophagogastroduodenoscopy is effective for secondary prevention of GC. Endoscopic findings of the stomach due to H. pylori infection vary widely, and the risk of GC varies according to each finding. GC risk is evaluated by combining endoscopic and histopathological findings. In the operative link on gastritis assessment and operative link on gastric intestinal metaplasia assessment staging, GC risk is determined by histopathological evaluation. In the endoscopic grading of gastric intestinal metaplasia, Kyoto classification, and modified Kyoto classification, the risk is considered based on endoscopic findings. However, evaluating endoscopic findings is challenging because the evaluation varies depending on the skill of the endoscopist. Similarly, histopathological findings can be assessed differently by different pathologists. Histopathological evaluation by biopsy carries a risk of bleeding; thus, simpler and less-invasive risk stratification methods are desirable. Artificial intelligence for risk stratification, which has the potential for improved accuracy and consistency, has been developed for endoscopic and histopathological evaluations. Appropriate GC risk stratification would benefit the economy and patients, and further evaluation of surveillance intervals tailored to individual risks is warranted.